Astrana Health, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Astrana Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 34% of its market value (net debt). Lower than 90% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times. Higher than 87% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
5.0×Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times.
Higher than 87% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$1Sales grew 178% in 3 years, but profit fell: $1 less profit per $100 of extra sales.
Lower than 69% of Healthcare companies in United States.
Asset Productivity Ratio
+178% / +130%In 3 years sales changed by +178% while total assets changed by +130%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.4×Debt due within a year is covered 2.4 times by its yearly operating cash.
Higher than 75% of Healthcare companies in United States.
Cash Cushion Ratio
−34%Debt, after subtracting cash, equals 34% of its market value (net debt).
Lower than 90% of Healthcare companies in United States.
Tangible Assets Ratio
49%Of every $100 the company owns, $49 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 82% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 86% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Astrana Health, Inc. owes $0.74 for every $1 it owns. Net profit fell 48% in the year to Dec 2025, and shrank 21% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
45.8Investors pay $45.8 for every $1 of Astrana Health, Inc.'s yearly profit, higher than 78% of Healthcare companies in United States.
P/B ratio
2.27The share price is 2.27 times Astrana Health, Inc.'s book value per share, lower than 54% of Healthcare companies in United States.
Market cap
$1.9 BThe total market value of all of Astrana Health, Inc.'s shares at today's price (share price × number of shares), larger than 73% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$830 MWhat Astrana Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$16.74Net worth divided by the number of shares. The share price of $38.01 is 2.3 times this, which is the P/B above.
Return on equity (ROE)
6.9%Astrana Health, Inc. earned 6.9% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
Owes vs Owns
0.74×Astrana Health, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Dividend yield
NoneAstrana Health, Inc. does not currently pay a dividend.
Revenue growth
+56%Revenue rose 56% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Profit growth
-48%Net profit fell 48% in the year to Dec 2025, and shrank 21% a year on average over 3 years.
Profit margin
0.7%Astrana Health, Inc. keeps $1 of every $100 of revenue as net profit.
Cash quality
5.1×Cash from Astrana Health, Inc.'s business was 5.1× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
1.6×Astrana Health, Inc.'s operating profit covered its interest costs 1.6 times in the year to Dec 2025.
Cash vs debt
Net debtAstrana Health, Inc. had $649 M more debt than cash (net debt) at Dec 2025.
Questions
What is Astrana Health, Inc.'s P/E ratio?
Investors pay $45.8 for every $1 of Astrana Health, Inc.'s yearly profit, higher than 78% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Astrana Health, Inc.: $1.9 B ÷ $830 M (30 Jun 2026) = 2.3.
What is Astrana Health, Inc.'s return on equity?
Astrana Health, Inc. earned 6.9% on its shareholders' money over the last year, higher than 81% of Healthcare companies in United States.
How much does Astrana Health, Inc. owe compared with what it owns?
Astrana Health, Inc. owes $0.74 for every $1 it owns (moderate), higher than 74% of Healthcare companies in United States.
Does Astrana Health, Inc. pay a dividend?
No. Astrana Health, Inc. does not currently pay a dividend.
Is Astrana Health, Inc.'s revenue growing?
Revenue rose 56% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.